Cargando…
A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies
BACKGROUND: That Epstein–Barr virus (EBV) infection is associated with systemic lupus erythematosus (SLE) is established. The challenge is to explain mechanistic roles EBV has in SLE pathogenesis. Previous studies identify four examples of autoantibody cross-reactions between SLE autoantigens and Ep...
Autores principales: | Laurynenka, Viktoryia, Ding, Lili, Kaufman, Kenneth M., James, Judith A., Harley, John B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892314/ https://www.ncbi.nlm.nih.gov/pubmed/35251022 http://dx.doi.org/10.3389/fimmu.2022.830993 |
Ejemplares similares
-
Comparison of different immunoassays detecting anti-chromatin autoantibodies in systemic lupus erythematosus (SLE)
por: Roux-Lombard, P, et al.
Publicado: (2002) -
ERK2 phosphorylation of EBNA1 serine 383 residue is important for EBNA1-dependent transactivation
por: Noh, Ka-Won, et al.
Publicado: (2016) -
Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA
por: Yadav, Pragya, et al.
Publicado: (2016) -
EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells
por: Glaser, Laura V., et al.
Publicado: (2017) -
Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)
por: Aringer, M, et al.
Publicado: (2003)